Ignite Creation Date:
2024-05-06 @ 8:19 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06334393
Status:
RECRUITING
Last Update Posted:
2024-03-28
First Post:
2024-03-06
Brief Title:
Phase 1 Trial to Assess the Safety and Immunogenicity of an Inactivated Adjuvanted Whole Zika Virus Vaccine Candidate VLA1601 in Healthy Adults
Sponsor:
Valneva Austria GmbH
Organization:
Valneva Austria GmbH
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-25
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-28
Completion Date Type:
ESTIMATED
First Submit Date:
2024-03-06
First Submit QC Date:
March 26 2024
Study First Post Date:
2024-03-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-26
Last Update Post Date:
2024-03-28
Last Update Post Date Type:
ACTUAL